Sumitomo Mitsui Trust Group
MD icon

Sumitomo Mitsui Trust Group’s Pediatrix Medical MD Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-256,322
Closed -$11.1M – 909
2017
Q3 		$11.1M Sell
256,322
-3,644
-1% -$173K 0.02% 648
2017
Q2 		$15.7M Buy
259,966
+2,287
+0.9% +$136K 0.02% 618
2017
Q1 		$17.9M Sell
257,679
-1,292
-0.5% -$89.7K 0.03% 580
2016
Q4 		$17.3M Sell
258,971
-1,057
-0.4% -$68.8K 0.03% 581
2016
Q3 		$17.2M Buy
260,028
+3,716
+1% +$254K 0.03% 573
2016
Q2 		$18.6M Sell
256,312
-5,386
-2% -$370K 0.03% 545
2016
Q1 		$16.9M Buy
261,698
+11,539
+5% +$765K 0.03% 568
2015
Q4 		$18M Buy
+250,159
New +$18.5M 0.03% 549
2015
Q3 		– Sell
-75,642
Closed -$5.61M – 886
2015
Q2 		$5.61M Buy
75,642
+6,176
+9% +$445K 0.01% 678
2015
Q1 		$5.04M Buy
69,466
+5,764
+9% +$401K 0.01% 666
2014
Q4 		$4.25M Sell
63,702
-25,685
-29% -$1.57M 0.01% 673
2014
Q3 		$4.9M Buy
+89,387
New +$5.07M 0.01% 657

Other funds holding MD

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BHG
Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

Sumitomo Mitsui Trust Group's MD Position: Q4 2017 in Review

Sumitomo Mitsui Trust Group sold out of Pediatrix Medical (MD) in Q4 2017, closing a stake of 256,322 shares — an estimated $11.1M sold.

Sumitomo Mitsui Trust Group first reported a position in MD in Q3 2014 and held it in 12 quarters. The position peaked at $18.6M in Q2 2016. 330 funds tracked by Wall St. Rank hold MD as of Q4 2017.

  • Sumitomo Mitsui Trust Group reported no remaining Pediatrix Medical position as of Q4 2017 after selling out during the quarter.
  • Sumitomo Mitsui Trust Group sold 256,322 Pediatrix Medical shares in Q4 2017, an estimated $11.1M.
  • Sumitomo Mitsui Trust Group first reported a position in Pediatrix Medical in Q3 2014 and held it in 12 quarters.
  • Sumitomo Mitsui Trust Group's Pediatrix Medical position peaked at $18.6M in Q2 2016.
  • 330 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2017.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q4 2017, filed 6 Feb 2018.